The Harmonized System (HS) code 30033900 pertains to "Other Medicaments containing hormones or other products of heading 2937 but not containing antibiotics, not elsewhere specified or included." This classification is utilized for certain potassium-based pharmaceutical products.
United States: According to the U.S. International Trade Commission (USITC), the Most Favored Nation (MFN) tariff rate for HS 30033900 is 0%. The U.S. Food and Drug Administration (FDA) provides exemptions for essential medicines, which may include certain potassium-based products, allowing for duty-free importation under specific conditions.
Hong Kong: As a free port, Hong Kong imposes no tariffs on pharmaceutical products, including those classified under HS 30033900. The Hong Kong Customs and Excise Department confirms that all pharmaceutical imports are duty-free, facilitating the importation of essential medicines.
Philippines: The Philippine Tariff Commission lists the MFN tariff rate for HS 30033900 as 0%. Under the ASEAN-India Free Trade Agreement (AIFTA), the preferential tariff rate is also 0%, promoting trade between India and the Philippines. The Philippine Food and Drug Administration (FDA) provides exemptions for essential medicines, potentially including potassium-based products, to ensure their affordability and availability.
Nigeria: The Nigeria Customs Service indicates that the MFN tariff rate for HS 30033900 is 0%. Nigeria's National Agency for Food and Drug Administration and Control (NAFDAC) offers exemptions for essential medicines, which may encompass certain potassium-based products, to support public health initiatives.
Germany: The German Customs Authority (Zoll) states that the MFN tariff rate for HS 30033900 is 0%. As a member of the European Union, Germany adheres to the EU's Common Customs Tariff, which provides for duty-free importation of pharmaceutical products. The European Medicines Agency (EMA) ensures that essential medicines, including potassium-based products, are accessible without additional tariffs.
